Event Brief
Mar 19, 2026 at 7:02 AM ET
Eli Lilly’s obesity drug retatrutide passes diabetes trial
By The BriefBrief
Eli Lilly's retatrutide shows promise in managing Type 2 diabetes and aiding weight loss in late-stage trial.
WHO: Eli Lilly
WHAT: retatrutide clears late-stage diabetes trial
WHEN: Mar 19, 2026 at 6:45 AM ET
WHERE: Location not specified
WHY: To help Type 2 diabetes patients manage blood sugar and lose weight
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21432 of 21432
Same format. Every time.
Continue reading — sign in or create a free account with
